Fixed brain tissues were cryoprotected and sectioned at 40 ucrom coronally and subjected to immunofluorescent staining using antibodies against TH (Immunostar #22941) and a-synuclein (C20, sc-7011-R; Santa Cruz), both at 1:100 dilution. Images were captured from Confocal microscope. Quantification was conducted using stereological principles (5 animals/group).
Figure Legends
Figure S1. Immuno double staining of TH and α-synuclein. Staining was performed and optimized on mid brain sections from α-synuclein transgenic mice generated previously (Lin 2012). Colocalization of these two antigens was found in dopaminergic neurons, in particular in older mice when α-synuclein pathology prevailed in the remaining TH neurons. Figure S2 . Effect of Piceid treatment in MPTP-induced PD mice. Daily ip injection of MPTP ( 20 mg/kg) for a continuous 7 days caused massive loss of TH neurons as well as weak α-synuclein staining in the SNc of male C57Bl/6 mice which were found to be largely prevented by daily piceid treatment (100 mg/kg, gavage). ** P< 0.01. Figure S3 . Effect of Piceid treatment in rotenone-induced PD rats. No α-synuclein pathology was found in SD rats after 5-week rotenone (2.0 mg/kg daily s. c. ) induction. Piceid largely rescued rats from dopaminergic neurodegeneration. Figure S4 . Effect of Piceid treatment in 6-OHDA-induced PD rats. Daily piceid treatment starting 2 hours after 6-OHDA injection for 7 days only partially protected dopaminergic neurons in VTA region but not in the SNc region. 
Reference

